recentpopularlog in

csrollyson : sh4   53

CAR-T has arrived in the clinic | MPNforum Magazine
Oncologist's post discusses ways to use CAR-T differently, i.e. the next wave
sh4  bullsi  cartcell  blog  2017  18sbx 
february 2019 by csrollyson
Dr. Sharman's CLL & Lymphoma Blog: Rituximab monotherapy in CLL
Great example of oncologist blog; in this post, he asks more patients to get involved in clinical trials for CAR-T
sh3  sh4  cartcell  bullsi  2014  18sbx 
february 2019 by csrollyson
Connecting Healthy Adults to People With Blood Cancers
Article about CAR-T for ALL + post on transplant patients and outcomes
18sbx  bullsi  ws1  sh4  ALL  transplant 
february 2019 by csrollyson
From “Incurable Cancer” to “Cancer Free” - How CAR T-Cell Immunotherapy Saved This 52-year old Lymphoma Patient
Interesting: seems like details are missing as post dated 2018 and it calls NHL "incurable" and "terminal" (misinformed CHP?)
sh4  sh1  example  cartcell  18sbx  2018  wisconsin 
february 2019 by csrollyson
Paying for CAR-T Treatment - The Myeloma Crowd
Useful detail that describes delays in insurance reimbursement for CAR-T
cartcell  insurance  example  reimbursement  hospital  atc  sh4  bullsi  18sbx  dlbcl  medicare  medicaid  payer 
february 2019 by csrollyson
Lindsay Norris – Here Comes the Sun
Oncology nurse starts blog to chronicle her treatment [no CAR-T but professional and raw at times]
sh3  sh4  sh1  18sbx  nurse  oncology  family  ATC 
february 2019 by csrollyson
Doctor Priorities vs. Patient Priorities
Interesting point: It's not unusual for cancer patients to priorities life events over treating their disease
sh3  sh4  sh1  conflict  lifestyle  cancer  example  disease  priority  treatment  ethics  communication  relationship  18sbx  bullsi 
february 2019 by csrollyson
The Patient Is Ready, But the Insurance Is Not
Superb: oncology fellow surveys his colleagues about their frustration with ponderous payer admin procedures [note twitter response]
sh3  sh4  bullsi  payer  insurance  administration  treatment  barrier  q1  2019  twitter  18sbx  oncology 
february 2019 by csrollyson
Dr. Sharman's CLL & Lymphoma Blog
Example of lymphoma physician blog; he hasn't written about CAR-T lately
sh4  blog  physician  cancer  chemotherapy  18sbx 
february 2019 by csrollyson
Towards the better diagnosis of lymphoma
Experimental blood tests measure DLBCL "DNA leakage" into the blood to predict relapse refractory disease
lymphoma  DLBCL  DNA  waste  blood  test  research  clinic  practice  oncologist  relapse  refractory  prediction  cancer  18sbx  bullsi  sh3  sh4 
january 2019 by csrollyson
CAR-T Therapy: Lifeline to A Cure? - Cancer Health
2 YESCARTA case studies for NHL and PMBCL patients highlight ATC interactions and patient and ATC physician quotes
patient  yescarta  casestudy  sh1  sh4  ATC  NHL  transplant  ASCT  radiation  referral  ws1  ws2  cartcell  18sbx  PMBCL  Q1  2018  bullsi2  bullsi 
january 2019 by csrollyson
decisions – getting closer and UCSF second opinion – Chemo log
Very detailed post on patient's cancer treatment decisions: here, CAR-T as second line vs. HDC/ASCT
patient  sh1  bullsi  dlbcl  ws1  chemotherapy  2ndline  3rdline  18sbx  insurance  hospital  ATC  sh4  bullsi2 
january 2019 by csrollyson
The Use of Chimeric Antigen Receptor T Cells in Patients With Non-Hodgkin Lymphoma – Hematology & Oncology
After a review of CAR-T use cases, risks and efficacies, author describes basic requirements for ATCs to prepare to offer the treatment
sh4  cartcell  ATC  yescarta  kymriah  18sbx  nhl  treatment  review 
january 2019 by csrollyson
Expert Highlights Use of CAR T-Cell Therapy in DLBCL
ATC physician discusses CAR-T therapy for r/r DLBCL, differences in Yescarta and Kymriah
SH4  18sbx  interview  cartcell  comparison  dlbcl  ATC  treatment  3rdline  refractory  relapse  bullsi 
january 2019 by csrollyson
How I manage patients with relapsed/refractory diffuse large B cell lymphoma
Superb in-depth paper presents patient journey from SH3/SH4 perspective through first-line, second-line, and third-line stages by discussing studies. Mentions CAR-T at conclusion
sh3  sh4  oncologist  physician  NHL  DLBCL  refractory  relapse  2ndline  3rdline  comparison  chemotherapy  transplant  highdose  bullsi  18sbx  bullsi2 
january 2019 by csrollyson
The CAR T-cell Chicago story: One year later – Science Life
Hospital-produced patient story of successful CAR T treatment; also discusses how ATC and community oncologist collaborated
ATC  18sbx  story  patient  comdoc  atcdoc  bullsi  ws1  ws2  ws3  sh1  sh3  sh4  uchicago 
june 2018 by csrollyson
(627) Furniture Design on Pinterest
Can do this for costume design, etc., to promo student/faculty/alum work
pinterest  bullsi  example  design  sh7  sh4  sh5 
december 2016 by csrollyson
GO TO CLASS. BE ENGAGED. YOU WILL BE FINE.
The only people I know who have disparaging commentary to make about Columbia are the people who were too busy smoking weed in the University Center to graduate. I graduated in 2009, and all the people I know who've tried to slaughter Columbia's reputation are people who flunked out, were dismissed, and dropped out because they discovered that they couldn't function as both student and artist.
16ccc  review  yelp  bullsi  alumni  student  sh5  sh4  humor 
december 2016 by csrollyson
Columbia College Chicago
Current Columbia student advises prospect
sh4  sh1  bullsi  16ccc  student  life  humor  professor  art  illustration 
august 2016 by csrollyson

Copy this bookmark:





to read